JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling

被引：14
作者：
Ren, Yanlin [1 ,2 ,5 ]
Chen, Dongyin [3 ]
Zhai, Zurong [1 ,2 ]
Chen, Junjie [1 ,2 ]
Li, Aiping [1 ,2 ]
Liang, Yan [2 ,4 ]
Zhou, Jianwei [1 ,2 ]
机构：
[1] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Dept Mol Cell Biol & Toxicol, Nanjing 211166, Peoples R China
[2] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatm, Nanjing 211166, Peoples R China
[3] Nanjing Med Univ, Sch Pharm, Dept Med Chem, Nanjing 211166, Peoples R China
[4] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing 211166, Peoples R China
[5] Nantong Ctr Dis Control & Prevent, Nantong 226007, Peoples R China
来源：
CELL DEATH DISCOVERY | 2021年 / 7卷 / 01期
基金：
中国国家自然科学基金;
关键词：
CELL-PROLIFERATION; GASTRIC-CANCER; LUNG-CANCER; JWA; EXPRESSION; GROWTH; RESISTANCE; MIGRATION; INVASION; HER2;
D O I：
10.1038/s41420-021-00426-y
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The overexpression of HER2 is associated with a malignant proliferation of breast cancer. In this study, we developed a non-cytotoxic JWA gene activating compound 1 (JAC1) to inhibit the proliferation of HER2-positive breast cancer cells in vitro and in vivo experimental models. JAC1 increased the ubiquitination of HER2 at the K716 site through the E3 ubiquitin ligase SMURF1 which was due to the decreased expression of NEDD4, the E3 ubiquitin ligase of SMURF1. In conclusion, JAC1 suppresses the proliferation of HER2-positive breast cancer cells through the JWA triggered HER2 ubiquitination signaling. JAC1 may serve as a potential therapeutic agent for HER2-positive breast cancer.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway
    Hsieh, Ming-Ju
    Chen, Kuo-Shuen
    Chiou, Hui-Ling
    Hsieh, Yih-Shou
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2010, 89 (08) : 598 - 606
  • [32] Constitutive HER2 Signaling Promotes Breast Cancer Metastasis through Cellular Senescence
    Davide Angelini, Pier
    Zacarias Fluck, Mariano F.
    Pedersen, Kim
    Lluis Parra-Palau, Josep
    Guiu, Marc
    Bernado Morales, Cristina
    Vicario, Rocio
    Luque-Garcia, Antonio
    Peiro Navalpotro, Nerea
    Giralt, Jordi
    Canals, Francesc
    Gomis, Roger R.
    Tabernero, Josep
    Baselga, Jose
    Villanueva, Josep
    Arribas, Joaquin
    CANCER RESEARCH, 2013, 73 (01) : 450 - 458
  • [33] MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2
    Li, Guang-Cai
    Cao, Xiao-Yun
    Li, Ying-Ni
    Qiu, Yu-Yan
    Li, Ying-Na
    Liu, Xing-Jie
    Sun, Xiang-Xiu
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (09) : 7379 - 7390
  • [34] Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition
    Wang, Juan
    Wang, Guanwen
    Cheng, Dongmei
    Huang, Shan
    Chang, Antao
    Tan, Xiaoming
    Wang, Qiong
    Zhao, Shaorong
    Wu, Dan
    Liu, Andy T.
    Yang, Shuang
    Xiang, Rong
    Sun, Peiqing
    ONCOGENE, 2020, 39 (40) : 6313 - 6326
  • [35] Protegrin-1 Regulates Porcine Granulosa Cell Proliferation via the EGFR-ERK1/2/p38 Signaling Pathway in vitro
    Pan, Bo
    Liu, Canying
    Zhan, Xiaoshu
    Li, Julang
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [36] PSKH1 affects proliferation and invasion of osteosarcoma cells via the p38/MAPK signaling pathway
    Zhu, Xingfei
    Jiang, Chao
    Wang, Zhiyuang
    Zhu, Xiaozhong
    Yuan, Feng
    Yang, Yi
    ONCOLOGY LETTERS, 2023, 25 (04)
  • [37] m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways
    Deng, Ru
    Cheng, Yikan
    Ye, Shubiao
    Zhang, Jianwei
    Huang, Runqing
    Li, Peisi
    Liu, Huashan
    Deng, Qiling
    Wu, Xianrui
    Lan, Ping
    Deng, Yanhong
    ONCOTARGETS AND THERAPY, 2019, 12 : 4391 - 4402
  • [38] MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer
    Ke, J.
    Zhang, B-H
    Li, Y-Y
    Zhong, M.
    Ma, W.
    Xue, H.
    Wen, Y-D
    Cai, Y-D
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (20) : 8870 - 8877
  • [39] FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
    Francis, Richard E.
    Myatt, Stephen S.
    Krol, Janna
    Hartman, Johan
    Peck, Barrie
    McGovern, Ursula B.
    Wang, Jun
    Guest, Stephanie K.
    Filipovic, Aleksandra
    Gojis, Ondrej
    Palmieri, Carlo
    Peston, David
    Shousha, Sami
    Yu, Qunyan
    Sicinski, Piotr
    Coombes, R. Charles
    Lam, Eric W. -F.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (01) : 57 - 68
  • [40] Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis
    Tang, Ya-Min
    Cao, Qing-Yun
    Guo, Xing-Yu
    Dong, Shui-Hua
    Duan, Jin-Ao
    Wu, Qi-Nan
    Liang, Qiao-Li
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 382 - 389
12345